Trial Profile
A Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile of Single Ascending Doses of REL-1017 (d-Methadone) in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs Esmethadone (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Acronyms SAD
- Sponsors Relmada Therapeutics
- 01 Apr 2019 Results from two studies evaluating the safety,pharmacokinetics and tolerability of oral doses of D-methadone in healthy opioid naive subjects,published in the Journal of Clinical Psychopharmacology
- 10 Jun 2015 Status changed from recruiting to completed, according to a Relmada Therapeutics media release.
- 17 Mar 2015 Status changed from not yet recruiting to recruiting according to Relmada media release.